Baker Heart & Diabetes Institute, Melbourne, Australia.
The Alfred Hospital, Melbourne, Australia.
Eur J Heart Fail. 2021 May;23(5):785-796. doi: 10.1002/ejhf.2122. Epub 2021 Mar 8.
The impact of atrial fibrillation (AF) ablation in early heart failure with preserved ejection fraction (HFpEF) is unknown. Our aim was to determine the impact of AF ablation on symptoms and exercise haemodynamic parameters of early HFpEF.
Symptomatic AF patients referred for index AF ablation with ejection fraction ≥50% underwent baseline quality of life questionnaires, echocardiography, cardiac magnetic resonance imaging, exercise right heart catheterisation (exRHC), and brain natriuretic peptide (BNP) testing. HFpEF was defined by resting pulmonary capillary wedge pressure (PCWP) ≥15 mmHg or peak exercise PCWP ≥25 mmHg. Patients with HFpEF were offered AF ablation and follow-up exRHC ≥6 months post-ablation. Of 54 patients undergoing baseline evaluation, 35 (65%) had HFpEF identified by exRHC. HFpEF patients were older (64 ± 10 vs. 54 ± 13 years, P < 0.01), and more frequently female (54% vs. 16%, P < 0.01), hypertensive (63% vs. 16%, P < 0.001), and suffering persistent AF (66% vs. 11%, P < 0.001), compared to those without HFpEF. Twenty HFpEF patients underwent AF ablation and follow-up exRHC 12 ± 6 months post-ablation. Nine (45%) patients no longer fulfilled exRHC criteria for HFpEF at follow-up. Patients remaining arrhythmia free (n = 9, 45%) showed significant improvements in peak exercise PCWP (29 ± 4 to 23 ± 2 mmHg, P < 0.01) and Minnesota Living with Heart Failure (MLHF) score (55 ± 30 to 22 ± 30, P < 0.01) while the remainder did not (PCWP 31 ± 5 to 30.0 ± 4 mmHg, P = NS; MLHF score 55 ± 23 to 25 ± 20, P = NS).
Heart failure with preserved ejection fraction frequently coexists in patients with symptomatic AF and preserved ejection fraction. Restoration and maintenance of sinus rhythm in patients with comorbid AF and HFpEF improves haemodynamic parameters, BNP and symptoms associated with HFpEF.
心房颤动(AF)消融对射血分数保留的心衰(HFpEF)早期的影响尚不清楚。我们的目的是确定 AF 消融对 HFpEF 早期患者症状和运动血液动力学参数的影响。
接受指数 AF 消融且射血分数≥50%的有症状 AF 患者进行基线生活质量问卷调查、超声心动图、心脏磁共振成像、运动右心导管检查(exRHC)和脑钠肽(BNP)检测。HFpEF 通过静息肺毛细血管楔压(PCWP)≥15mmHg 或峰值运动 PCWP≥25mmHg 来定义。HFpEF 患者接受 AF 消融治疗,并在消融后≥6 个月进行 exRHC 随访。在接受基线评估的 54 名患者中,35 名(65%)通过 exRHC 确定存在 HFpEF。HFpEF 患者年龄更大(64±10 岁 vs. 54±13 岁,P<0.01),更常为女性(54% vs. 16%,P<0.01)、高血压(63% vs. 16%,P<0.001)和持续性 AF(66% vs. 11%,P<0.001)。与无 HFpEF 患者相比。20 名 HFpEF 患者接受 AF 消融治疗,并在消融后 12±6 个月进行 exRHC 随访。9 名(45%)患者在随访时不再符合 HFpEF 的 exRHC 标准。无心律失常的患者(n=9,45%)在峰值运动 PCWP(从 29±4mmHg 降至 23±2mmHg,P<0.01)和明尼苏达州心力衰竭生活质量量表(MLHF)评分(从 55±30 分降至 22±30 分,P<0.01)方面均有显著改善,而其余患者则没有(PCWP 从 31±5mmHg 降至 30.0±4mmHg,P=NS;MLHF 评分从 55±23 分降至 25±20 分,P=NS)。
射血分数保留的心力衰竭在有症状的射血分数保留的 AF 患者中经常共存。合并 AF 和 HFpEF 的患者恢复和维持窦性心律可改善与 HFpEF 相关的血液动力学参数、BNP 和症状。